Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation

American Journal of Respiratory and Critical Care Medicine

Volumn 181, Issue 8, 2010, Pages 851-861

  Girerd, Barbara ^a,b,c   Montani, David ^a,b,c   Coulet, Florence ^d   Sztrymf, Benjamin ^b   Yaici, Azzeddine ^b   Jaïs, Xavier ^b   Tregouet, David ^d   Reis, Abilio ^e   Drouin Garraud, Valérie ^f   Fraisse, Alain ^g   Sitbon, Olivier ^a,b,c   O'Callaghan, Dermot S ^a,b,c   Simonneau, Gérald ^a,b,c   Soubrier, Florent ^d   Humbert, Marc ^a,b,c  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

^c Universite Paris Sud   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^f HÔPITAL CHARLES NICOLLE   (France)

^g TIMONE HOSPITAL   (France)

Author keywords

BMPR2; Bone morphogenetic protein receptor type 2; Hemodynamic; Hereditary hemorrhagic telangiectasia; Pulmonary hypertension

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; BOSENTAN; ILOPROST; PROSTACYCLIN; SILDENAFIL; ACTIVIN RECEPTOR 2; ACVRL1 PROTEIN, HUMAN; BMPR2 PROTEIN, HUMAN; OXYGEN;

ADOLESCENT; ADULT; ARTERIOVENOUS MALFORMATION; ARTICLE; CAUSE OF DEATH; CLINICAL FEATURE; DATA BASE; DISEASE COURSE; EPISTAXIS; FAMILY HISTORY; FEMALE; FOLLOW UP; GENE MUTATION; HEART RIGHT VENTRICLE FAILURE; HEMODYNAMICS; HETEROZYGOTE; HUMAN; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POINT MUTATION; PRIORITY JOURNAL; PROGNOSIS; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; RENDU OSLER WEBER DISEASE; SUDDEN DEATH; SURVIVAL TIME; WALKING; AGE DISTRIBUTION; BLOOD; BLOOD PRESSURE; CHILD; EXERCISE TEST; FRANCE; GENE DELETION; GENETICS; INFANT; LUNG WEDGE PRESSURE; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PULMONARY ARTERY; REGISTER; STATISTICS; SURVIVAL; VASCULAR RESISTANCE;

ACTIVIN RECEPTORS, TYPE II; ADOLESCENT; ADULT; AGE DISTRIBUTION; BLOOD PRESSURE; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; CHILD; CHILD, PRESCHOOL; EXERCISE TEST; FEMALE; FRANCE; HUMANS; HYPERTENSION, PULMONARY; INFANT; MALE; MIDDLE AGED; OXYGEN; POINT MUTATION; PULMONARY ARTERY; PULMONARY WEDGE PRESSURE; REGISTRIES; SEQUENCE DELETION; SURVIVAL ANALYSIS; VASCULAR RESISTANCE; YOUNG ADULT;

EID: 77953067153     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200908-1284OC     Document Type: Article

References (44)

1. Rubin L. Primary pulmonary hypertension. N Engl J Med 1997;336: 111-117.
2. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004;351:1425-1436.
3. Simonneau G, Galiè N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, Gibbs S, Lebrec D, Speich R, Beghetti M, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004;43:5S-12S.
4. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54:S43-S54.
5. Machado RD, Eickelberg O, Elliott CG, Geraci MW, Hanaoka M, Loyd JE, Newman JH, Phillips JA III, Soubrier F, Trembath RC, et al. Genetics and genomics of pulmonary arterial hypertension. J Am Coll Cardiol 2009;54:S32-S42.
6. Rosenzweig EB, Morse JH, Knowles JA, Chada KK, Khan AM, Roberts KE, McElroy JJ, Juskiw NK, Mallory NC, Rich S, et al. Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension. J Heart Lung Transplant 2008;27:668-674.
7. Sztrymf B, Coulet F, Girerd B, Yaici A, Jais X, Sitbon O, Montani D, Souza R, Simonneau G, Soubrier F, et al. Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation. Am J Respir Crit Care Med 2008;177:1377-1383.
8. Humbert M. Update in pulmonary hypertension 2008. Am J Respir Crit Care Med 2009;179:650-656.
9. Aldred MA, Machado RD, James V, Morrell NW, Trembath RC. Characterization of the BMPR2 59-untranslated region and a novel mutation in pulmonary hypertension. Am J Respir Crit Care Med 2007;176:819-824.
10. Cogan JD, Pauciulo MW, Batchman AP, Prince MA, Robbins IM, Hedges LK, Stanton KC, Wheeler LA, Phillips JA III, Loyd JE, et al. High frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertension. Am J Respir Crit Care Med 2006; 174:590-598.
11. Thomson J, Machado R, Pauciulo M, Morgan N, Yacoub M, Corris P, McNeil K, Loyd J, Nichols W, Trembath R. Familial and sporadic primary pulmonary hypertension is caused by BMPR2 gene mutations resulting in haploinsufficiency of the bone morphogenetic protein type II receptor. J Heart Lung Transplant 2001;20:149.
12. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, et al.; Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC); European Respiratory Society (ERS); International Society of Heart and Lung Transplantation (ISHLT). Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009;34:1219-1263.
13. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, et al.; Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC); European Respiratory Society (ERS); International Society of Heart and Lung Transplantation (ISHLT). Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2009;30:2493-2537.
14. Montani D, O'Callaghan D, Jaïs X, Savale L, Natali D, Redzepi A, Hoette S, Parent F, Sitbon O, Simonneau G, et al. Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre. Eur Respir Rev 2009;18:231-249.
15. Guttmacher AE, Marchuk DA, White RI Jr. Hereditary hemorrhagic telangiectasia. N Engl J Med 1995;333:918-924.
16. Shovlin CL, Letarte M. Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms. Thorax 1999;54:714-729.
17. Begbie ME, Wallace GM, Shovlin CL. Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century. Postgrad Med J 2003;79:18-24.
18. Shovlin CL, Jackson JE, Bamford KB, Jenkins IH, Benjamin AR, Ramadan H, Kulinskaya E. Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia. Thorax 2008;63:259-266.
19. Cottin V, Plauchu H, Bayle JY, Barthelet M, Revel D, Cordier JF. Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia. Am J Respir Crit Care Med 2004;169: 994-1000. (Pubitemid 38543636)
20. Govani FS, Shovlin CL. Hereditary haemorrhagic telangiectasia: a clinical and scientific review. Eur J Hum Genet 2009;17:860-871.
21. Trembath R, Thomson J, Machado RD, Morgan NV, Atkinson C, Winship I, Simonneau G, Galiè N, Loyd JE, Humbert M, et al. Clinical and molecular genetic features of pulmonary hypertension in hereditary hemorrhagic telangiectasia. N Engl J Med 2001;345:325-334.
22. Plauchu H, de Chadarevian JP, Bideau A, Robert JM. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 1989;32:291-297.
23. Cole SG, Begbie ME, Wallace GM, Shovlin CL. A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet 2005;42:577-582.
24. Gallione CJ, Repetto GM, Legius E, Rustgi AK, Schelley SL, Tejpar S, Mitchell G, Drouin E, Westermann CJ, Marchuk DA. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 2004; 363:852-859.
25. Harrison RE, Flanagan JA, Sankelo M, Abdalla SA, Rowell J, Machado RD, Elliott CG, Robbins IM, Olschewski H, McLaughlin V, et al. Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia. J Med Genet 2003;40:865-871.
26. Abdalla SA, Gallione CJ, Barst RJ, Horn EM, Knowles JA, Marchuk DA, Letarte M, Morse JH. Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia. Eur Respir J 2004;23:373-377.
27. Harrison RE, Berger R, Haworth SG, Tulloh R, Mache CJ, Morrell NW, Aldred MA, Trembath RC. Transforming growth factor-β receptor mutations and pulmonary arterial hypertension in childhood. Circulation 2005;111:435-441. (Pubitemid 40204427)
28. Fujiwara M, Yagi H, Matsuoka R, Akimoto K, Furutani M, Imamura S, Uehara R, Nakayama T, Takao A, Nakazawa M, et al. Implications of mutations of activin receptor-like kinase 1 gene (ALK1) in addition to bone morphogenetic protein receptor II gene (BMPR2) in children with pulmonary arterial hypertension. Circ J 2008;72:127-133.
29. Chaouat A, Coulet F, Favre C, Simonneau G, Weitzenblum E, Soubrier F, Humbert M. Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension. Thorax 2004;59:446-448.
30. Elliott CG, Glissmeyer EW, Havlena GT, Carlquist J, McKinney JT, Rich S, McGoon MD, Scholand MB, Kim M, Jensen RL, et al. Relationship of BMPR2 mutations to vasoreactivity in pulmonary arterial hypertension. Circulation 2006;113:2509-2515. (Pubitemid 43948029)
31. McGoon M, Gutterman D, Steen V, Barst R, McCrory DC, Fortin TA, Loyd JE. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004;126:14S-34S.
32. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006;173:1023-1030.
33. Sitbon O, Humbert M, Jais X, Ioos V, Hamid AM, Provencher S, Garcia G, Parent F, Herve P, Simonneau G. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 2005;111:3105-3111.
34. Sitbon O, Humbert M, Nunes H, Parent F, Garcia G, Herve P, Rainisio M, Simonneau G. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 2002;40:780-788. (Pubitemid 34925627)
35. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-117.
36. Smoot LB, Obler D, McElhinney D, Boardman K, Wu BL, Lip V, Mullen MP. Clinical features of pulmonary arterial hypertension in young people with an ALK1 mutation and hereditary hemorrhagic telangiectasia. Arch Dis Child 2009;94:506-511.
37. Montani D, Price LC, Girerd B, Chinet T, Lacombe P, Simonneau G, Humbert M. Fatal rupture of pulmonary arteriovenous malformation in hereditary haemorragic telangiectasis and severe PAH. Eur Respir Rev 2009;111:42-46.
38. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O, Voelkel NF, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43:13S-24S.
39. Faughnan M, Young L, Granton J. The pulmonary vascular complications of hereditary haemorrhagic telangiectasia. Eur Respir J 2009;33: 1186-1194.
40. David L, Mallet C, Mazerbourg S, Feige JJ, Bailly S. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 2007;109: 1953-1961.
41. ten Dijke P, Arthur HM. Extracellular control of TGFb signalling in vascular development and disease. Nat Rev Mol Cell Biol 2007;8: 857-869.
42. Garamszegi N, Dore JJ Jr, Penheiter SG, Edens M, Yao D, Leof EB. Transforming growth factor b receptor signaling and endocytosis are linked through a COOH terminal activation motif in the type I receptor. Mol Biol Cell 2001;12:2881-2893. (Pubitemid 33051951)
43. Sztrymf B, Yaici A, Girerd B, Humbert M. Genes and pulmonary arterial hypertension. Respiration 2007;74:123-132.
44. Machado RD, James V, Southwood M, Harrison RE, Atkinson C, Stewart S, Morrell NW, Trembath RC, Aldred MA. Investigation of second genetic hits at the BMPR2 locus as a modulator of disease progression in familial pulmonary arterial hypertension. Circulation 2005;111:607-613.